These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16544756)

  • 1. [Pharmacoprophylaxis of sea-sickness syndrome with the help of homeopathic drug "Avia-more"].
    Salenko IuA; Barchukov VG; Sergeeva SA; Vorob'ev OA; Ponomarenko KV; Palamarchuk AM; Gracheva ON; Barchukov VV
    Voen Med Zh; 2006 Jan; 327(1):55-9, 96. PubMed ID: 16544756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
    Noy S; Shapira S; Zilbiger A; Ribak J
    Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diazepam as an anti-motion sickness drug.
    McClure JA; Lycett P; Baskerville JC
    J Otolaryngol; 1982 Aug; 11(4):253-9. PubMed ID: 7131636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin as a countermeasure for motion sickness in NASA maritime operations.
    Woodard D; Knox G; Myers KJ; Chelen W; Ferguson B
    Aviat Space Environ Med; 1993 May; 64(5):363-6. PubMed ID: 8503807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose ondansetron for reducing motion sickness in highly susceptible subjects.
    Muth ER; Elkins AN
    Aviat Space Environ Med; 2007 Jul; 78(7):686-92. PubMed ID: 17679566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motion-sickness medications for aircrew: impact on psychomotor performance.
    Paul MA; MacLellan M; Gray G
    Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
    Pyykkö I; Padoan S; Schalén L; Lyttkens L; Magnusson M; Henriksson NG
    Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electroencephalographic studies on a dimenhydrinate in a chewing-gum for motion sickness].
    Reimann HJ; Erbel F
    Ther Ggw; 1981 Sep; 120(9):837-44. PubMed ID: 7292363
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of anti-seasick properties of pyrroxan and dimenhydrinate under conditions of maximal and submaximal statokinetic load in humans].
    Shabanov PD; Anokhin AG
    Eksp Klin Farmakol; 2005; 68(3):50-5. PubMed ID: 16047682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the therapy of motion sickness: the dimenhydrinate-containing chewing gum dragee].
    Reimann HJ; Erbel F; Bergemann B
    Ther Ggw; 1981 Dec; 120(12):1171-80. PubMed ID: 7330785
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenytoin for motion sickness: clinical evaluation.
    Knox GW; Woodard D; Chelen W; Ferguson R; Johnson L
    Laryngoscope; 1994 Aug; 104(8 Pt 1):935-9. PubMed ID: 8052077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind placebo controlled evaluation of acupressure in the treatment of motion sickness.
    Warwick-Evans LA; Masters IJ; Redstone SB
    Aviat Space Environ Med; 1991 Aug; 62(8):776-8. PubMed ID: 1930060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of betahistine for the prevention of seasickness: effect on vestibular function, psychomotor performance and efficacy at sea.
    Gordon CR; Doweck I; Nachum Z; Gonen A; Spitzer O; Shupak A
    J Vestib Res; 2003; 13(2-3):103-11. PubMed ID: 14757913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroendocrine factors in pathogenesis of motion sickness and the protective effect of drugs].
    Shashkov AV; Karsanova SK; Iasnetsov VV; Tigranian RA; Shashkov VS
    Eksp Klin Farmakol; 2004; 67(2):3-7. PubMed ID: 15188750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of motion sickness with selegilinum hydrochloricum.
    Bodó G; Elkán K; Bencze G
    Ther Hung; 1989; 37(2):103-6. PubMed ID: 2511643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Italian Air Force rehabilitation programme for air-sickness.
    Lucertini M; Lugli V
    Acta Otorhinolaryngol Ital; 2004 Aug; 24(4):181-7. PubMed ID: 15688901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of some motion sickness suppressants on static and dynamic tracking performance.
    Schroeder DJ; Collins WE; Elam GW
    Aviat Space Environ Med; 1985 Apr; 56(4):344-50. PubMed ID: 3994616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Homeopathy in acute rhinosinusitis: a double-blind, placebo controlled study shows the efficiency and tolerability of a homeopathic combination remedy].
    Friese KH; Zabalotnyi DI
    HNO; 2007 Apr; 55(4):271-7. PubMed ID: 17180695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of some antimotion sickness drugs and secobarbital on postural equilibrium functions at sea level and at 12,000 feet (simulated).
    Fregly AR; Smith MJ; Wood CD; Cramer DB
    Aerosp Med; 1973 Feb; 44(2):140-5. PubMed ID: 4687828
    [No Abstract]   [Full Text] [Related]  

  • 20. Transdermal scopolamine in the prevention of motion sickness at sea.
    Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G
    Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.